World Wide relies on analytics signals to operate securely and keep research services available. Accept to continue, or leave the site.
Review the Privacy Policy for details about analytics processing.
Dr
Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden- Rossendorf (HDZR), Germany
Showing your local timezone
Schedule
Thursday, October 13, 2022
7:30 AM Australia/Melbourne
Domain
NeuroscienceOriginal Event
View sourceHost
Ad hoc
Duration
70 minutes
Bispidines (3,7-diazabicyclo[3.3.1]nonane) and their derivatives act as bifunctional chelators (BFC), combining the advantages of multidentate macrocyclic and acyclic ligands e.g. high kinetic inertness, rapid radiolabelling under mild conditions. This bicyclic chelator system shows a great diversity in terms of its denticity and type of functional groups, yielding a wide range of multidentate ligands that can bind a variety of different metal ions. In addition, they allow a facile functionalisation of targeting molecules such as peptides, peptidomimetics, and bispecic antibodies. Herein, examples of various bispidine complexes labelled with [64Cu]Cu2+, [111In]In3+, [ 177Lu]Lu3+ or [ 225Ac]Ac3+ will be presented which provide a picture of how different substituents inuence the coordination mode. Target-specic radiolabelled bispidine-based conjugates (e.g. peptides, antibody fragments, antibodies) investigated in vivo by positron emission or single-photon emission computed tomography will be presented and discussed in terms of their suitability for nuclear medicine applications.
Manja Kubeil
Dr
Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden- Rossendorf (HDZR), Germany
Contact & Resources
neuro
neuro
neuro